February 26, 2020 / 1:13 PM / a month ago

BRIEF-Cyclo Therapeutics Announces Completion Of Enrollment In Its Extension Protocol To The Phase I Trial To Evaluate Trappsol Cyclo

Feb 26 (Reuters) - Ctd Holdings Inc:

* CYCLO THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN ITS EXTENSION PROTOCOL TO THE PHASE I TRIAL TO EVALUATE TRAPPSOL® CYCLO™ FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below